Cargando…

Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis

Non-alcoholic steatohepatitis (NASH) is gradually becoming one of the most common and health-endangering diseases; therefore, it is very important to prevent the occurrence of NASH and prevent simple non-alcoholic fatty liver (NAFL) from further developing into NASH. We fed mice a high-fat diet (HFD...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chao, Wan, Min, Xu, Dengfeng, Pan, Da, Xia, Hui, Yang, Ligang, Sun, Guiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509295/
https://www.ncbi.nlm.nih.gov/pubmed/34639207
http://dx.doi.org/10.3390/ijms221910858
_version_ 1784582304378650624
author Yang, Chao
Wan, Min
Xu, Dengfeng
Pan, Da
Xia, Hui
Yang, Ligang
Sun, Guiju
author_facet Yang, Chao
Wan, Min
Xu, Dengfeng
Pan, Da
Xia, Hui
Yang, Ligang
Sun, Guiju
author_sort Yang, Chao
collection PubMed
description Non-alcoholic steatohepatitis (NASH) is gradually becoming one of the most common and health-endangering diseases; therefore, it is very important to prevent the occurrence of NASH and prevent simple non-alcoholic fatty liver (NAFL) from further developing into NASH. We fed mice a high-fat diet (HFD, 60% fat) for 14 weeks to induce NAFL and then fed different doses of flaxseed powder (low (10%), middle (20%), and high (30%)) to the mice for 28 weeks. After the animal experiment, we analyzed fecal bile acid (BA) profiles of the HFD mice, flaxseed-fed (FLA-fed) mice, and control mice with a normal diet (10% fat) using a targeted metabolomics approach, and we analyzed the gut microbiota at the same time. We also investigated the mechanistic role of BAs in NASH and identified whether the altered BAs strongly bind to colonic FXR or TGR5. In the present study, we found that 28-week FLA treatment notably alleviated NASH development in NAFL model mice fed with an HFD, and the beneficial effects may be attributed to the regulation of and improvement in the gut flora- and microbiota-related BAs, which then activate the intestinal FXR-FGF15 and TGR5-NF-κB pathways. Our data indicate that FLA might be a promising functional food for preventing NASH through regulating microbiomes and BAs.
format Online
Article
Text
id pubmed-8509295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85092952021-10-13 Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis Yang, Chao Wan, Min Xu, Dengfeng Pan, Da Xia, Hui Yang, Ligang Sun, Guiju Int J Mol Sci Article Non-alcoholic steatohepatitis (NASH) is gradually becoming one of the most common and health-endangering diseases; therefore, it is very important to prevent the occurrence of NASH and prevent simple non-alcoholic fatty liver (NAFL) from further developing into NASH. We fed mice a high-fat diet (HFD, 60% fat) for 14 weeks to induce NAFL and then fed different doses of flaxseed powder (low (10%), middle (20%), and high (30%)) to the mice for 28 weeks. After the animal experiment, we analyzed fecal bile acid (BA) profiles of the HFD mice, flaxseed-fed (FLA-fed) mice, and control mice with a normal diet (10% fat) using a targeted metabolomics approach, and we analyzed the gut microbiota at the same time. We also investigated the mechanistic role of BAs in NASH and identified whether the altered BAs strongly bind to colonic FXR or TGR5. In the present study, we found that 28-week FLA treatment notably alleviated NASH development in NAFL model mice fed with an HFD, and the beneficial effects may be attributed to the regulation of and improvement in the gut flora- and microbiota-related BAs, which then activate the intestinal FXR-FGF15 and TGR5-NF-κB pathways. Our data indicate that FLA might be a promising functional food for preventing NASH through regulating microbiomes and BAs. MDPI 2021-10-08 /pmc/articles/PMC8509295/ /pubmed/34639207 http://dx.doi.org/10.3390/ijms221910858 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yang, Chao
Wan, Min
Xu, Dengfeng
Pan, Da
Xia, Hui
Yang, Ligang
Sun, Guiju
Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
title Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
title_full Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
title_fullStr Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
title_full_unstemmed Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
title_short Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
title_sort flaxseed powder attenuates non-alcoholic steatohepatitis via modulation of gut microbiota and bile acid metabolism through gut–liver axis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509295/
https://www.ncbi.nlm.nih.gov/pubmed/34639207
http://dx.doi.org/10.3390/ijms221910858
work_keys_str_mv AT yangchao flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis
AT wanmin flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis
AT xudengfeng flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis
AT panda flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis
AT xiahui flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis
AT yangligang flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis
AT sunguiju flaxseedpowderattenuatesnonalcoholicsteatohepatitisviamodulationofgutmicrobiotaandbileacidmetabolismthroughgutliveraxis